GLP-1 drugs: what Texas Medicaid paid

Q: Does a paid prescription mean Texas Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Texas Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. A paid prescription records what happened and is not permission for what happens next, so read the figures below as a payment history rather than as a coverage rule.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Texas Medicaid’s payment record shows

In 2026Q1, the product Texas Medicaid paid for most often was Ozempic®, at 24,392 prescriptions¹⁹ of the 45,444 to 45,651^{1,7,13,19,25,37,43} across all 8 products, or 54 percent of the published count.

Texas Medicaid itself reimbursed at least $47,429,435 for these products in the quarter, about $1,044 per prescription. Pharmacies were paid $49,352,116 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,338.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Texas Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Texas Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Texas Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Texas Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 1,417¹	3%	$1,373,823	$1,495,485	$970
tirzepatideMounjaro®	Both16,424 managed care, 13 direct	at least 16,437⁷	36%	$17,878,813	$18,782,604	$1,088
semaglutideWegovy®	Managed care	at least 1,989¹³	4%	$2,320,736	$2,587,320	$1,167
semaglutideOzempic®	Both24,320 managed care, 72 direct	24,392¹⁹	54%	$24,692,556	$25,282,438	$1,012
semaglutideRybelsus®	Managed care	720²⁵	2%	$963,179	$1,003,474	$1,338
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 121³⁷	<1%	$72,476	$72,476	$599
liraglutideliraglutide (generic)	Managed care	at least 345⁴³	<1%	$127,853	$128,319	$371

Texas Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 12.3 prescriptions per thousand people enrolled in Texas Medicaid, on an average of 3,698,515 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 23 of the 168 product-quarters it holds a row for here, which is 14 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Texas Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Texas Medicaid paid for each product, quarter by quarter

Prescriptions Texas Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable²Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable²Withheld5 of 5 product codes withheld	at least 348 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$330,041 paid	at least 1,417 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$1,373,823 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹¹No row	at least 681 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$637,019 paid	at least 2,794 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$2,561,086 paid	at least 4,109 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$3,734,441 paid	at least 4,631 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$4,494,151 paid	at least 5,226 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$5,309,024 paid	at least 5,943 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$5,973,718 paid	at least 7,509 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$7,718,348 paid	at least 8,595 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$8,844,553 paid	at least 9,652 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$10,103,026 paid	at least 11,711 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$12,543,895 paid	at least 12,837 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$13,684,464 paid	at least 14,544 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$15,116,677 paid	at least 16,437 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$17,878,813 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld5 of 5 product codes withheld	at least 16 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$20,154 paid	at least 39 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$48,307 paid	at least 627 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$673,754 paid	at least 1,062 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$1,211,042 paid	at least 1,309 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$1,518,116 paid	at least 1,640 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$1,960,956 paid	at least 1,989 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$2,320,736 paid
semaglutideOzempic®range 22,048 to 24,392, up 562 on the quarter before	at least 1,938 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,638,665 paid	at least 2,375 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$2,037,955 paid	at least 2,823 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$2,383,022 paid	at least 3,461 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,886,134 paid	at least 4,092 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$3,403,801 paid	at least 4,974 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$4,218,016 paid	at least 5,524 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$4,955,441 paid	at least 5,733 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$5,194,059 paid	at least 9,733 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$8,957,941 paid	at least 15,912 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$14,383,929 paid	at least 18,125 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$16,010,010 paid	at least 15,746 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$14,189,029 paid	at least 17,427 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$16,402,159 paid	at least 21,328 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$19,813,897 paid	at least 21,985 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$20,525,220 paid	23,229 paid prescriptions in the quarter (2024Q4)²¹Count$21,774,080 paid	22,048 paid prescriptions in the quarter (2025Q1)²⁰Count$21,486,044 paid	23,219 paid prescriptions in the quarter (2025Q2)²⁰Count$22,927,508 paid	23,221 paid prescriptions in the quarter (2025Q3)²⁰Count$22,717,737 paid	23,830 paid prescriptions in the quarter (2025Q4)²⁰Count$22,982,829 paid	24,392 paid prescriptions in the quarter (2026Q1)¹⁹Count$24,692,556 paid
semaglutideRybelsus®range 392 to 720	at least 272 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$241,327 paid	392 paid prescriptions in the quarter (2021Q2)³⁰Count$325,082 paid	at least 559 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$445,257 paid	at least 650 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$539,949 paid	at least 666 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$566,709 paid	at least 903 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$817,353 paid	at least 915 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$907,458 paid	at least 885 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$876,303 paid	at least 1,113 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$1,140,515 paid	at least 1,132 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$1,184,320 paid	at least 1,048 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$1,084,006 paid	at least 985 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$1,067,475 paid	at least 961 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$1,054,154 paid	at least 1,015 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$1,080,946 paid	at least 947 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$1,032,977 paid	at least 903 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$997,264 paid	at least 791 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$935,799 paid	at least 787 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$961,962 paid	at least 705 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$879,027 paid	at least 591 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$717,705 paid	720 paid prescriptions in the quarter (2026Q1)²⁵Count$963,179 paid
liraglutideSaxenda®range 11 to 16	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	11 paid prescriptions in the quarter (2022Q2)³⁵Count$13,743 paid	16 paid prescriptions in the quarter (2022Q3)³⁵Count$19,708 paid	14 paid prescriptions in the quarter (2022Q4)³⁵Count$15,041 paid	15 paid prescriptions in the quarter (2023Q1)³⁴Count$15,301 paid	12 paid prescriptions in the quarter (2023Q2)³⁴Count$15,558 paid	13 paid prescriptions in the quarter (2023Q3)³⁴Count$16,949 paid	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®	at least 5,341 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld⁴²At least$4,814,022 paid	at least 5,971 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld⁴²At least$5,402,717 paid	at least 6,286 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld⁴²At least$5,403,885 paid	at least 6,028 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld⁴²At least$5,176,312 paid	at least 5,825 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$5,200,223 paid	at least 5,913 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld⁴¹At least$5,312,326 paid	at least 5,678 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$5,110,491 paid	at least 5,179 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld⁴¹At least$4,687,940 paid	at least 5,148 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$4,885,344 paid	at least 4,589 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$4,400,869 paid	at least 3,917 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$3,747,757 paid	at least 3,153 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$3,018,693 paid	at least 2,276 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$1,580,448 paid	at least 1,866 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$1,234,458 paid	at least 1,324 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$852,952 paid	1,027 paid prescriptions in the quarter (2024Q4)³⁹Count$674,288 paid	at least 543 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$333,087 paid	at least 205 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$126,041 paid	at least 194 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$123,222 paid	at least 141 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$91,438 paid	at least 121 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$72,476 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 95 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$46,126 paid	422 paid prescriptions in the quarter (2025Q2)⁴⁴Count$189,803 paid	at least 407 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$174,181 paid	at least 421 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$165,128 paid	at least 345 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$127,853 paid

What Texas Medicaid publishes as the rule

The figures above are payments. The rule that decides the next request is a different document, and where this site has read it the jurisdiction page carries it with the quote. Read the Texas Medicaid coverage page.

Open Texas in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, TX
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "599"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, TX
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "200"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, TX
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, TX
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like ZEPBOUND%, state TX, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, TX
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like ZEPBOUND%, state TX, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, TX
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like ZEPBOUND%, state TX, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, TX
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "3596"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, TX
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "3257"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, TX
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2196"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, TX
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1419"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, TX
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like MOUNJARO%, state TX, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, TX
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like MOUNJARO%, state TX, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, TX
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "false", "number_of_prescriptions": "456"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, TX
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "399"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, TX
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, TX
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, TX
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, TX
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, TX
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "8813"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, TX
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "9095"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, TX
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "9810"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, TX
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "9574"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, TX
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2817"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, TX
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1749"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, TX
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "294"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, TX
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "323"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, TX
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "466"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, TX
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "528"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, TX
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "448"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, TX
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "345"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, TX
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like SAXENDA%, state TX, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, TX
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, TX
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, TX
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "false", "number_of_prescriptions": "15"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, TX
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, TX
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, TX
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, TX
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "332"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, TX
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1432"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, TX
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "3261"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, TX
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "3655"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, TX
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "3726"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, TX
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state TX, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TX", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "81"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, TX
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state TX, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "182"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, TX
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state TX, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like LIRAGLUTID%, state TX, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, TX
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state TX, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like LIRAGLUTID%, state TX, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, TX
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state TX, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like LIRAGLUTID%, state TX, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, TX
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state TX, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TX", "product_name": "product_name like LIRAGLUTID%, state TX, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 38 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 10 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Texas Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.